Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Current Taxes (2020 - 2026)

Ironwood Pharmaceuticals' Current Taxes history spans 5 years, with the latest figure at $927000.0 for Q4 2025.

  • On a quarterly basis, Current Taxes rose 77.93% to $927000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $927000.0, a 77.93% increase, with the full-year FY2025 number at $927000.0, up 77.93% from a year prior.
  • Current Taxes hit $927000.0 in Q4 2025 for Ironwood Pharmaceuticals, up from $656000.0 in the prior quarter.
  • Over the last five years, Current Taxes for IRWD hit a ceiling of $6.6 million in Q2 2023 and a floor of $521000.0 in Q4 2024.
  • Historically, Current Taxes has averaged $1.4 million across 4 years, with a median of $931000.0 in 2024.
  • Biggest five-year swings in Current Taxes: surged 89.63% in 2023 and later plummeted 85.93% in 2024.
  • Tracing IRWD's Current Taxes over 4 years: stood at $656000.0 in 2022, then surged by 89.63% to $1.2 million in 2023, then crashed by 58.12% to $521000.0 in 2024, then skyrocketed by 77.93% to $927000.0 in 2025.
  • Business Quant data shows Current Taxes for IRWD at $927000.0 in Q4 2025, $656000.0 in Q3 2025, and $764000.0 in Q2 2025.